Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion type Assertion NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_head.
- NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion description "[This conditions NER efficiency and transcription resumption after damage, which in human cells would explain the XP-CS phenotype, opening new perspectives to understand the molecular basis of the role of XPD in human disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_provenance.
- NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion evidence source_evidence_literature NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_provenance.
- NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion SIO_000772 25500814 NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_provenance.
- NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion wasDerivedFrom befree-2016 NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_provenance.
- NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_assertion wasGeneratedBy ECO_0000203 NP1247405.RA_nABWRuXeRoFft8vqUOFR2oqVAYMpFT-VQJ2GnQDy3w130_provenance.